Overall patient outcome is dependent on the stage of disease. Patients with earlier stage disease (ie. stage one) have improved overall survival as compared to patients with later stage disease (ie. stage four). The most important thing to remember regarding hearing statistics such as this is that each patient is different, and there is a potential for cure in every stage of disease.
There are multiple treatment options available for patients with stage four disease which include both surgical and non-surgical options depending on patient factors, including location and extent of disease and performance status.
With the development of new therapies for metastatic colorectal cancer, there have been improvements in survival. Many of these treatment options involve a multidisciplinary approach, and should be tailored to the individual patient depending on the location and the extent of metastatic disease.
Learn more about SurvivorNet's rigorous medical review process.
Dr. Heather Yeo is a medical advisor to SurvivorNet. She is board-certified in general surgery, colon and rectal surgery, and complex general surgical oncology. She is an assistant professor of Surgery and Healthcare Policy and Research at Weill Cornell Medical College and assistant attending surgeon at NewYork-Presbyterian/Weill Cornell Medical Center. Read More
Overall patient outcome is dependent on the stage of disease. Patients with earlier stage disease (ie. stage one) have improved overall survival as compared to patients with later stage disease (ie. stage four). The most important thing to remember regarding hearing statistics such as this is that each patient is different, and there is a potential for cure in every stage of disease.
There are multiple treatment options available for patients with stage four disease which include both surgical and non-surgical options depending on patient factors, including location and extent of disease and performance status.
Read More
With the development of new therapies for metastatic colorectal cancer, there have been improvements in survival. Many of these treatment options involve a
multidisciplinary approach, and should be tailored to the individual patient depending on the location and the extent of metastatic disease.
Learn more about SurvivorNet's rigorous medical review process.
Dr. Heather Yeo is a medical advisor to SurvivorNet. She is board-certified in general surgery, colon and rectal surgery, and complex general surgical oncology. She is an assistant professor of Surgery and Healthcare Policy and Research at Weill Cornell Medical College and assistant attending surgeon at NewYork-Presbyterian/Weill Cornell Medical Center. Read More
